NO304830B1 - Substituerte bicykliske heteroaroylguanidiner, deres anvendelse for fremstilling av medikament eller diagnostikum sÕvel som medikamenter inneholdende dem - Google Patents
Substituerte bicykliske heteroaroylguanidiner, deres anvendelse for fremstilling av medikament eller diagnostikum sÕvel som medikamenter inneholdende demInfo
- Publication number
- NO304830B1 NO304830B1 NO951736A NO951736A NO304830B1 NO 304830 B1 NO304830 B1 NO 304830B1 NO 951736 A NO951736 A NO 951736A NO 951736 A NO951736 A NO 951736A NO 304830 B1 NO304830 B1 NO 304830B1
- Authority
- NO
- Norway
- Prior art keywords
- drugs
- poly
- diagnostics
- manufacture
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4415873A DE4415873A1 (de) | 1994-05-05 | 1994-05-05 | Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO951736D0 NO951736D0 (no) | 1995-05-04 |
| NO951736L NO951736L (no) | 1995-11-06 |
| NO304830B1 true NO304830B1 (no) | 1999-02-22 |
Family
ID=6517371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951736A NO304830B1 (no) | 1994-05-05 | 1995-05-04 | Substituerte bicykliske heteroaroylguanidiner, deres anvendelse for fremstilling av medikament eller diagnostikum sÕvel som medikamenter inneholdende dem |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6093729A (da) |
| EP (1) | EP0682017B1 (da) |
| JP (1) | JP3774771B2 (da) |
| KR (1) | KR950032129A (da) |
| CN (1) | CN1117045A (da) |
| AT (1) | ATE183179T1 (da) |
| AU (1) | AU693861B2 (da) |
| CA (1) | CA2148666A1 (da) |
| DE (2) | DE4415873A1 (da) |
| DK (1) | DK0682017T3 (da) |
| ES (1) | ES2136767T3 (da) |
| FI (1) | FI952117A7 (da) |
| GR (1) | GR3031539T3 (da) |
| HU (1) | HUT72089A (da) |
| IL (1) | IL113606A0 (da) |
| NO (1) | NO304830B1 (da) |
| NZ (1) | NZ272058A (da) |
| TW (1) | TW429252B (da) |
| ZA (1) | ZA953588B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5627193A (en) * | 1995-02-09 | 1997-05-06 | Mitsui Toatsu Chemicals, Inc. | Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds |
| DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
| DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
| DE19548812A1 (de) * | 1995-12-27 | 1997-07-03 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation |
| CA2195697A1 (en) * | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
| DE19621482A1 (de) | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| CA2283404A1 (en) | 1997-03-06 | 1998-09-11 | Jun Sasamori | Cycloalka¬b|pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same |
| JP2002502414A (ja) * | 1997-06-02 | 2002-01-22 | 藤沢薬品工業株式会社 | 細胞中のＮａ▲上＋▼／Ｈ▲上＋▼交換の阻害剤としてのグアニジン誘導体 |
| AU4481899A (en) * | 1998-02-20 | 1999-09-06 | Takeda Chemical Industries Ltd. | Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| US6706732B1 (en) | 1999-06-03 | 2004-03-16 | Takeda Chemical Industries, Ltd. | Nasal preparation of guanidinoimino quinoline derivatives |
| EP1646371A4 (en) * | 2003-06-26 | 2010-09-22 | Biotron Ltd | ANTIVIRAL COMPOSITIONS AND METHODS |
| CN104370813A (zh) * | 2014-10-22 | 2015-02-25 | 上海大学 | 异喹啉-6-甲醛的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
| DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| EP0556674B1 (de) * | 1992-02-15 | 1996-06-19 | Hoechst Aktiengesellschaft | 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen |
| CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
| ATE158278T1 (de) * | 1992-02-15 | 1997-10-15 | Hoechst Ag | Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
| DK0590455T3 (da) * | 1992-09-28 | 2001-01-22 | Hoechst Ag | Antiarrytmiske og cardioprotektive substiuerede 1(2H)-isoquinoliner, fremgangsmåde til deres fremstilling, lægemiddel indeh |
-
1994
- 1994-05-05 DE DE4415873A patent/DE4415873A1/de not_active Withdrawn
- 1994-09-30 TW TW083109021A patent/TW429252B/zh active
-
1995
- 1995-05-02 EP EP95106596A patent/EP0682017B1/de not_active Expired - Lifetime
- 1995-05-02 ES ES95106596T patent/ES2136767T3/es not_active Expired - Lifetime
- 1995-05-02 DK DK95106596T patent/DK0682017T3/da active
- 1995-05-02 JP JP10854795A patent/JP3774771B2/ja not_active Expired - Fee Related
- 1995-05-02 AT AT95106596T patent/ATE183179T1/de not_active IP Right Cessation
- 1995-05-02 DE DE59506564T patent/DE59506564D1/de not_active Expired - Lifetime
- 1995-05-03 NZ NZ272058A patent/NZ272058A/en unknown
- 1995-05-03 CN CN95105390A patent/CN1117045A/zh active Pending
- 1995-05-03 IL IL11360695A patent/IL113606A0/xx unknown
- 1995-05-03 AU AU17861/95A patent/AU693861B2/en not_active Ceased
- 1995-05-03 FI FI952117A patent/FI952117A7/fi unknown
- 1995-05-04 CA CA002148666A patent/CA2148666A1/en not_active Abandoned
- 1995-05-04 KR KR1019950011160A patent/KR950032129A/ko not_active Ceased
- 1995-05-04 HU HU9501285A patent/HUT72089A/hu unknown
- 1995-05-04 ZA ZA953588A patent/ZA953588B/xx unknown
- 1995-05-04 NO NO951736A patent/NO304830B1/no not_active IP Right Cessation
-
1998
- 1998-11-18 US US09/195,098 patent/US6093729A/en not_active Expired - Lifetime
-
1999
- 1999-10-15 GR GR990402626T patent/GR3031539T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1117045A (zh) | 1996-02-21 |
| KR950032129A (ko) | 1995-12-20 |
| NO951736L (no) | 1995-11-06 |
| FI952117A0 (fi) | 1995-05-03 |
| FI952117L (fi) | 1995-11-06 |
| NO951736D0 (no) | 1995-05-04 |
| AU693861B2 (en) | 1998-07-09 |
| AU1786195A (en) | 1995-11-16 |
| DE4415873A1 (de) | 1995-11-09 |
| JP3774771B2 (ja) | 2006-05-17 |
| DK0682017T3 (da) | 1999-12-13 |
| FI952117A7 (fi) | 1995-11-06 |
| ES2136767T3 (es) | 1999-12-01 |
| US6093729A (en) | 2000-07-25 |
| ATE183179T1 (de) | 1999-08-15 |
| EP0682017B1 (de) | 1999-08-11 |
| CA2148666A1 (en) | 1995-11-06 |
| EP0682017A1 (de) | 1995-11-15 |
| HUT72089A (en) | 1996-03-28 |
| IL113606A0 (en) | 1995-08-31 |
| GR3031539T3 (en) | 2000-01-31 |
| ZA953588B (en) | 1996-06-16 |
| JPH0841028A (ja) | 1996-02-13 |
| DE59506564D1 (de) | 1999-09-16 |
| NZ272058A (en) | 1996-02-27 |
| TW429252B (en) | 2001-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0682017T3 (da) | Substituerede bicycliske heteroaroylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller | |
| MX9100062A (es) | Composiciones en polvo para revestimiento para la fabricacion de las mismas | |
| FI924311A0 (fi) | Nya 2-substituerade indan-2 -merkaptoacetylamidderivat anvaendbara som inhibitorer av enkefalinas och ace. | |
| DK0481522T3 (da) | Nye mercaptoacetylamid-derivater anvendelige som inhibitorer af enkephalinase og ACE | |
| EE03178B1 (et) | Kondenseerunud bitsüklilist tuuma sisaldavad ühendid, nende vaheproduktid, valmistamismeetodid ja farmatseutilised kompositsioonid | |
| SE8902326D0 (sv) | Karboxamidfoereningar, foerfaranden foer framstaellning av dem och farmceutiska kompositioner som innehaaller dem | |
| FI954304A0 (fi) | Uudet bentsopyraanijohdannaiset, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| DK256990D0 (da) | Kondenserede polycykliske forbindelser, praeparater, fremstillingsfremgangsmaader og anvendelse deraf som paf-antagonister, antihistaminer og/eller antiinflammatoriske midler | |
| FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
| AR229801A1 (es) | Nuevos derivados de 2-fenoxi-3-(n'-fenil)-nicotinamida,procedimientos para su preparacion y composiciones herbicidas que los contienen | |
| DK160788D0 (da) | 2-oen-phenyl(eller phenoxy)alkyl-n-methyl-aminoaaindan-forbindelser, anvendelse af sulfonamido-derivater blandt disse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende sulfonamiderne | |
| DK50086D0 (da) | 3-phenyl-tetrahydropyridinderivater | |
| MX9300628A (es) | Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| DK488588D0 (da) | Sulfonamid-forbindelser, farmaceutiske praeparater indeholdende disse og anvendelse af forbindelserne til fremstilling af antiarytmiske laegemidler | |
| DK81184D0 (da) | Anvendelse af i 2-stillingen med (substituerede) aminogrupper substituerede 4-dl-alkylester-alfa-alaninyl-6-chlor-s-triaziner som herbicider, isaer mod flyvehavre | |
| DK431489D0 (da) | Lipoprotein i (ompi) af pseudomonas aeruginosa, dets fremstilling og anvendelse | |
| PT861837E (pt) | Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| DK160688A (da) | Ae5-alkylsulfonamido-2-(n-alkylsulfonamidoheterocyclylmethyl-n-methyl-amino)indan-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende sulfonamiderne samt 2-(n-methylamino)indan-forbindelser, der er nyttige som mellemprodukterae | |
| ES499154A0 (es) | Procedimiento para la preparacion de fenil eteres y tioeteres sustituidos y sus sales. | |
| DK671087D0 (da) | Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva | |
| SE8602525L (sv) | Fenantrenderivat | |
| BR9704113A (pt) | Composto de novos bisimidas processo para prepará-los e composições farmacêuticas contendo os mesmos | |
| DK0477552T3 (da) | Anvendelse af 10-ring-lactoner som lipidregulatorer | |
| ES2150081T3 (es) | Nuevos derivados del tiofeno, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| BR9101973A (pt) | Compostos quimicos,processo para a sua preparacao e composicoes farmaceutica e terapeutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |